ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,965.25
      -0.30%
      US Tech 100
      20,524.80
      -1.30%
      Dow Jones
      43,654.64
      0.45%
      Brent Oil
      72.575
      -2.56%
      Bitcoin
      87,255.95
      -4.58%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. TransMedics Group Inc (TMDX) Quote

      TransMedics Group Inc

      TransMedics Group Inc (TMDX)

      NASDAQ
      73.86
      -3.26
      ( -4.23% )
      Updated: 14:27:08
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      73.86
      Bid
      73.72
      Ask
      73.90
      Volume
      1,510,311
      72.37 Day's Range 76.33
      55.00 52 Week Range 177.37
      Market Cap
      2.479B
      Previous Close
      77.12
      Open
      75.00
      Last Trade
      24
      @
      73.86
      Last Trade Time
      14:27:08
      Financial Volume
      $ 111,604,579
      VWAP
      73.8951
      Average Volume (3m)
      1,976,510
      Shares Outstanding
      33,561,517
      Dividend Yield
      -
      PE Ratio
      -98.22
      Earnings Per Share (EPS)
      -0.75
      Revenue
      241.62M
      Net Profit
      -25.03M

      About TransMedics Group Inc

      TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a porta... TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body. Show more

      Sector
      Electromedical Apparatus
      Industry
      Electromedical Apparatus
      Website
      www.transmedics.com
      Headquarters
      Andover, Massachusetts, USA
      Founded
      -
      TransMedics Group Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker TMDX. The last closing price for TransMedics was $77.12. Over the last year, TransMedics shares have traded in a share price range of $ 55.00 to $ 177.37.

      TransMedics currently has 33,561,517 shares outstanding. The market capitalization of TransMedics is $2.59 billion. TransMedics has a price to earnings ratio (PE ratio) of -98.22.

      Ask ADVFN Intelligence (AI)

      TransMedics (TMDX) Options Flow Summary

      TMDX Options Flow

      Overall Flow

      Bullish

      Net Premium

      478k

      Calls / Puts

      160,00%

      Buys / Sells

      18,18%

      OTM / ITM

      116,67%

      Sweeps Ratio

      0,00%

      TMDX Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 21 2025
      TMDX (-4.23%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 14 2025
      TMDX (-4.23%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.370.50346985984573.4979.99571.5012135635476.18229384CS
      412.3920.156173743361.4779.99560.46134024471.5383417CS
      12-3.605-4.6537145807877.46582.3755197651067.46522502CS
      26-102.15-58.0364752003176.0117755172691391.04552301CS
      52-8.14-9.9268292682982177.37551282718100.81243757CS
      15657.59353.96435156716.27177.3716.0476385283.15856501CS
      26056.43323.75215146317.43177.371057237171.48500514CS

      TMDX - Frequently Asked Questions (FAQ)

      What is the current TransMedics share price?
      The current share price of TransMedics is $ 73.86
      How many TransMedics shares are in issue?
      TransMedics has 33,561,517 shares in issue
      What is the market cap of TransMedics?
      The market capitalisation of TransMedics is USD 2.59B
      What is the 1 year trading range for TransMedics share price?
      TransMedics has traded in the range of $ 55.00 to $ 177.37 during the past year
      What is the PE ratio of TransMedics?
      The price to earnings ratio of TransMedics is -98.22
      What is the cash to sales ratio of TransMedics?
      The cash to sales ratio of TransMedics is 10.17
      What is the reporting currency for TransMedics?
      TransMedics reports financial results in USD
      What is the latest annual turnover for TransMedics?
      The latest annual turnover of TransMedics is USD 241.62M
      What is the latest annual profit for TransMedics?
      The latest annual profit of TransMedics is USD -25.03M
      What is the registered address of TransMedics?
      The registered address for TransMedics is 200 MINUTEMAN ROAD, ANDOVER, MASSACHUSETTS, 01810
      What is the TransMedics website address?
      The website address for TransMedics is www.transmedics.com
      Which industry sector does TransMedics operate in?
      TransMedics operates in the ELECTROMEDICAL APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ONVOOrganovo Holdings Inc
      $ 1.2184
      (230.19%)
      		344.29M
      WAFUWah Fu Education Group Ltd
      $ 3.079
      (72.01%)
      		115.84M
      RETOReTo Eco Solutions Inc
      $ 1.01
      (71.19%)
      		64.12M
      SLXNSilexion Therapeutics Corporation
      $ 1.09
      (45.33%)
      		84.22M
      BREABrera Holdings PLC
      $ 0.905001
      (43.36%)
      		73.1M
      YYAIConnexa Sports Technologies Inc
      $ 0.7305
      (-42.48%)
      		5.12M
      RNAZTransCode Therapeutics Inc
      $ 3.90
      (-42.48%)
      		499.75k
      CLNEClean Energy Fuels Corp
      $ 1.835
      (-32.29%)
      		9.12M
      ACONAclarion Inc
      $ 3.1996
      (-31.34%)
      		317.62k
      SXTCChina SXT Pharmaceuticals Inc
      $ 4.65
      (-30.80%)
      		1M
      ONVOOrganovo Holdings Inc
      $ 1.2184
      (230.19%)
      		339.24M
      NVDANVIDIA Corporation
      $ 127.355
      (-2.25%)
      		194.33M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 13.975
      (-19.36%)
      		137.52M
      WAFUWah Fu Education Group Ltd
      $ 3.079
      (72.01%)
      		115.33M
      PLTRPalantir Technologies Inc
      $ 87.3297
      (-3.69%)
      		106.35M

      TMDX Discussion

      View Posts
      Monksdream Monksdream 10 months ago
      TMDX new 52+ week high
      👍️0
      Monksdream Monksdream 1 year ago
      TMDX 10Q
      👍️0
      make it happen make it happen 1 year ago
      Should touch $50 net lose widens, and has a 40% day. The structure shows over 100% ownership which technically should be illegal. How can there be over 100%? Imho mean institutions and whomever will be selling for a 40%ish profit overnight.
      👍️0
      crudeoil24 crudeoil24 4 years ago
      TransMedics Late Tuesday Announced FDA Advisory Committee Panel Voted 12 To 5 That Benefits Of OCS Heart System Outweigh Risks
      6:58 am ET April 7, 2021 (Benzinga) Print
      TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ("CAP") results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks. The panel voted 10 to 6, with 2 abstaining, that there is reasonable assurance that the OCS Heart System is effective. The panel voted 9 to 7, with 2 abstaining, that there is reasonable assurance of the OCS Heart System's safety.

      © 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Lung INSPIRE Trial, OCS Lung Expand Trial, OCs Heart EXPAND and PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. It is also focused on developing additional OCS products for kidney transplantation.
      👍️0

      Your Recent History

      NASDAQ
      TMDX
      TransMedics
      BIT
      P1RRA9
      BNP Paribas Issuance
      BIT
      P16207
      Bnp Paribas Issuance
      BIT
      UC5CET
      Unicredit Bank
      BIT
      P1MA22
      BNP Paribas Issuance
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads